|
TMEM106C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.20829999999906E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.241100E-03 |
| Normal-vs-Stage2 |
4.691600E-02 |
| Normal-vs-Stage3 |
2.077300E-03 |
| Normal-vs-Stage4 |
1.228470E-02 |
| Stage1-vs-Stage2 |
6.479000E-01 |
| Stage1-vs-Stage3 |
7.366300E-02 |
| Stage1-vs-Stage4 |
2.793900E-02 |
| Stage2-vs-Stage3 |
3.606600E-01 |
| Stage2-vs-Stage4 |
1.166200E-01 |
| Stage3-vs-Stage4 |
3.924200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.76479999999657E-05 |
| Normal-vs-AfricanAmerican |
1.679880E-03 |
| Normal-vs-Asian |
6.329000E-01 |
| Caucasian-vs-AfricanAmerican |
8.168800E-01 |
| Caucasian-vs-Asian |
6.096600E-01 |
| AfricanAmerican-vs-Asian |
6.302600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.220400E-04 |
| Normal-vs-Female |
7.89010000000756E-05 |
| Male-vs-Female |
1.068800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.574410E-02 |
| Normal-vs-Extreme_Weight |
1.981660E-02 |
| Normal-vs-Obese |
1.198790E-03 |
| Normal-vs-Extreme_Obese |
5.483400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.480000E-01 |
| Normal_Weight-vs-Obese |
7.186400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.701600E-01 |
| Extreme_Weight-vs-Obese |
5.447200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.926400E-01 |
| Obese-vs-Extreme_Obese |
3.972600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.460120E-02 |
| Normal-vs-Age(41-60Yrs) |
4.208000E-04 |
| Normal-vs-Age(61-80Yrs) |
9.431800E-04 |
| Normal-vs-Age(81-100Yrs) |
6.098300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.420600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.016200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.255000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.418800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.596400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.901000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.837490E-04 |
| Normal-VS-Type2 PRCC |
7.588600E-04 |
| Normal-VS-KIRP CIMP |
4.492000E-02 |
| Normal-VS-Unclassified PRCC |
2.350400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.754200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.405000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.818200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.952160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.202800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.498800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.858000E-02 |
| Normal-vs-N1 |
2.202200E-03 |
| Normal-vs-N2 |
2.0456000000002E-05 |
| N0-vs-N1 |
1.755890E-02 |
| N0-vs-N2 |
1.547860E-02 |
| N1-vs-N2 |
3.846200E-01 |
|
|
